INTRANASAL DELIVERY OF PNEUMOCOCCAL POLYSACCHARIDE VACCINES

摘要

The invention relates to a method for preventing against diseases induced by Streptococcus pneumoniae infections, which comprises mucosally administering to a patient in need of a S. pneumoniae capsular polysaccharide. This latter may be conjugated or not and is preferably mixed with a mucosal adjuvant suc h as cholera toxin, E. coli heatlabile toxin or RhinovaxTM. A preferred route of administration is the intranasal route.